Malignant melanoma is a very serious disease with a relatively poor prognosis. Melanoma growth stimulatory activity (MGSA) is a growth regulatory protein which is over-expressed in melanoma and several other human tumors. Characterization of the mechanism by which MGSA acts may lead to new methods of therapeutic intervention for those tumors which overexpress identical with the human gro gene and closely related, if not identical, to the human PDGF inducible KC gene. The mature 73 amino acid protein is apparently derived form proteolytic cleavage of a 107 amino acid precursor. Antagonism of MGSA bioactivity with antibodies to MGSA slows the growth of Hs294T melanoma cells. When the MGSA/KC/gro DNA is transfected into Chinese hamster ovary cells, conditioned medium from these cultures has MGSA bioactivity which can be blocked with antibody to MGSA. 125I-MGSA binds to Hs294T melanoma cells and a number of other cell types which exhibit a bioresponse to MGSA, including PC3 prostatic carcinoma, NRK fibroblast, Calu 6, and A427 lung carcinoma, Balbc/3T3 fibroblasts, MeWo melanoma and nervus 106 cultures. 125I-MGSA disuccinimidyl suberate crosslinking studies reveal that MGSA binds to membrane associated proteins of 45,000, 64,000 and 184,000 Mr in Hs294T cells. For some cells this binding event results in phosphorylation of an 80,000 Mr protein on ser/thr. Experiments described here aim to (1) determine the effects of over-expression of MGSA on the growth of nontransformed cells [MGSA DNA will be transfected into nevus and fibroblast cultures. Transfectants will be studied for changes in double times, growth in serum-free medium, tumor formation in nude mice, and induction of collagen, laminin, and fibronectin synthesis]. (2) examine the effects of MGSA antagonist [including antisense MGSA oligonucleotides, antisense MGSA DNA transfection, and liposome mediated transfection with antibodies to MGSA] on growth of cells overexpressing MGSA. (3) utilize ligand affinity chromatography to purify the MGSA receptor [Recombinant MGSA will be purified in sufficient quantity to utilize ligand affinity purification and to obtain enriched MGSA- receptor preparations. These enriched preparations will be further purified by RP-HPLC and/or gel filtration and ion exchange HPLC and antibodies to the receptor will be raised in the rabbit.] (4) determine the signal transduction mechanism for MGSA [specifically, tyrosine kinase, protein kinase C, Ca++, inositol lipids cAMP dependent protein kinase, and G-proteins will be studied].

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA034590-10
Application #
3172325
Study Section
Pathology B Study Section (PTHB)
Project Start
1983-04-01
Project End
1994-03-31
Budget Start
1991-04-01
Budget End
1992-03-31
Support Year
10
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Yang, Jinming; Kumar, Amrendra; Vilgelm, Anna E et al. (2018) Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms. Cancer Immunol Res 6:1186-1198
Pellom Jr, Samuel T; Dudimah, Duafalia F; Thounaojam, Menaka C et al. (2017) Bortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function. Oncotarget 8:8604-8621
Lavender, Nicole; Yang, Jinming; Chen, Sheau-Chiann et al. (2017) The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo. BMC Cancer 17:88
Sai, Jiqing; Owens, Philip; Novitskiy, Sergey V et al. (2017) PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 Responses. Clin Cancer Res 23:3371-3384
Duvall-Noelle, N; Karwandyar, A; Richmond, A et al. (2016) LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex. Oncogene 35:1122-33
Richmond, Ann; Yang, Jinming (2016) The role of NF-kB in modulating antitumor immunity. Oncoimmunology 5:e1005522
Vilgelm, Anna E; Johnson, C Andrew; Prasad, Nripesh et al. (2016) Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment. J Natl Cancer Inst 108:djv406
Sobolik, Tammy; Su, Ying-Jun; Ashby, Will et al. (2016) Development of novel murine mammary imaging windows to examine wound healing effects on leukocyte trafficking in mammary tumors with intravital imaging. Intravital 5:e1125562
Saxon, Jamie A; Sherrill, Taylor P; Polosukhin, Vasiliy V et al. (2016) Epithelial NF-?B signaling promotes EGFR-driven lung carcinogenesis via macrophage recruitment. Oncoimmunology 5:e1168549
Johnson, Douglas B; Estrada, Monica V; Salgado, Roberto et al. (2016) Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy. Nat Commun 7:10582

Showing the most recent 10 out of 74 publications